The Biggest Problem Facing Cannabinoid Therapies and the

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
47
The Biggest Problem Facing Cannabinoid Therapies and the Company That is Doubling Down on Solutions -- CFN Media

SEATTLE, WA--(Marketwired - Oct 2, 2017) - CFN Media Group ("CannabisFN"), the leading creative agency and media network dedicated to legal cannabis, announces publication of an article discussing Pivot Pharmaceuticals Inc. ( OTCQB : PVOTF ). The company has staked its business on transdermal and oral encapsulation cannabinoid delivery, which eliminates the negative side effects of inhaled cannabis and avoids first-pass metabolism in the liver. After acquiring the worldwide rights to BiPhasix™, the company doubled down on another drug pharmaceutical delivery technology by locking up the worldwide rights to Solmic Solubilisation -- a proprietary oral delivery technology.

Medical cannabis has the potential to address everything from childhood epilepsy to the opioid epidemic, but there's a big problem that researchers are facing when developing therapeutics -- there's no robust delivery mechanism available.

In a 2009 study , researchers found that bioavailability was wildly unpredictable for inhaled cannabis smoke (2% to 56%) and orally-consumed cannabinoids (4% to 20%). Many patients aren't interested in smoking cannabis, but orally-consumed cannabis is subject to first-pass metabolism in the liver that mitigates its benefits. Topical delivery has become an alternative, but these formulations suffer from poor absorption and greasiness and oiliness.

What Makes It Different?

Pivot Pharma's BiPhasix™ technology has been tested in FDA and EMA approved human clinical trials and been used to deliver an antiviral drug to treat infections in women. In regulated studies, BiPhasix™ has been shown to improve drug permeation through the skin. Ongoing research shows that Biphasix™ is a non-invasive drug delivery system suitable for intra- and transdermal delivery of cannabinoids.

Acquisition of the worldwide rights to the Solmic Solubilisation Technology represents an expansion of Pivot's cannabinoid delivery strategy. By packing active pharmaceutical ingredients in micelles, the innovative technology enables active ingredients to become water soluble without changing their composition and nature. These micelles mask unpleasant smells and tastes and increase the uptake of fat soluble ingredients into the gut and blood stream.

"Solmic's water soluble technology has already been demonstrated in the nutraceutical and cosmeceutical markets in Europe," said Pivot Pharma CEO Patrick Frankham. "The addition to Solmic, our second disruptive drug delivery technology platform for cannabinoids, strengthens our business strategy to be a market leader in the development and commercialization of cannabinoid, cannabidiol (CBD), and tetrahydrocannabinol (THC) based products."

The combination of oral and transdermal delivery enables the company to develop therapeutics targeting a wide range of conditions.

Impressive Clinical Pipeline

Pivot Pharma is leveraging its cannabinoid delivery technology platforms to develop a robust pipeline of clinical products. The BiPhasix™ platform is targeting topical creams, while the Solmic platform targets orally consumed products.

PGS-N005 is a CBD topical cream developed with BiPhasix™ for the treatment of female sexual dysfunction. Despite up to 63% of sexually active women in the U.S. affected by FSD, the condition hasn't garnered the same level of attention as male erectile dysfunction. Analysts believe that the FSD market could be worth more than $4 billion per year with a patient population of more than 50 million individuals.

PGS-N007 is a CBD topical cream developed with BiPhasix™ for the treatment of psoriasis. According to the National Psoriasis Foundation, the condition affects 7.5 million people in the United States with a global prevalence range of 0.09% to 11.4%. Analysts believe that the market could be grow from $6.6 billion in 2014 to over $13.3 billion by 2024, which represents a 7.3% compound annual growth rate.

Using the Solmic technology platform, PGS-N001 will become the company's first oral product incorporating cannabinoids to help cancer patients suffering from chemotherapy-induced vomiting, nausea, neutropenia, and anemia. The product will be registered as a Natural Health Product to shorten the development cycle and generate revenue more quickly than traditional pharmaceuticals with an estimated $30 billion market by 2021.

Please follow the link to read the full article: http://www.cannabisfn.com/biggest-problem-fac...solutions/

About CFN Media

CFN Media (CannabisFN) is the leading creative agency and media network dedicated to legal cannabis. We help marijuana businesses attract investors, customers (B2B, B2C), capital, and media visibility. Private and public marijuana companies and brands in the US and Canada rely on CFN Media to grow and succeed.

Learn how to become a CFN Media client company, brand or entrepreneur: http://www.cannabisfn.com/featuredcompany

Download the CFN Media iOS mobile app to access the world of cannabis from the palm of your hand: https://itunes.apple.com/us/app/cannabisfn/id...?ls=1&mt=8

Or visit our homepage and enter your mobile number under the Apple App Store logo to receive a download link text on your iPhone: http://www.cannabisfn.com

Disclaimer:

Except for the historical information presented herein, matters discussed in this release contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Emerging Growth LLC, which owns CFN Media and CannabisFN.com, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Emerging Growth LLC may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice. Emerging Growth LLC may be compensated for its services in the form of cash-based compensation or equity securities in the companies it writes about, or a combination of the two. For full disclosure please visit: http://www.cannabisfn.com/legal-disclaimer/

CFN Media Frank Lane 2063697050 flane@cannabisfn.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Isar’s Nova Scotia Pad Build Gives MAXQ a Real Test

Updated Category News Views 350

Concrete work is where space ambition stops being a brochure. Isar Aerospace has taken operational responsibility for its dedicated launch infrastructure at Spaceport Nova Scotia, and construction is beginning on the Canadian launch pad it will use. For Maritime Launch Services, this is the sort of update that deserves more than the usual starry-eyed applause. A Site...

Continue Reading
D-Wave Investors Face a December 15 Lead Plaintiff Clock

Updated Category News Views 233

August Put the Story Under a Harsh Light Two ugly August trading sessions are doing a lot of work in the case now confronting D-Wave Quantum. The company sits in a field that attracts big dreams, big headlines, and, frankly, plenty of investor imagination. But imagination does not cushion a portfolio when expectations crack. The lawsuits concern people who bought or...

Continue Reading
PettiChat’s Digital Pet Twin Has Real Consumer Pull

Updated Category News Views 165

A Collar Gadget Is Chasing the Empty-House Problem Leave a dog or cat alone for a few hours and plenty of owners turn into amateur detectives. Did the cat eat? Has the dog been pacing? Why was that one weird noise caught on the home camera? Seattle startup PettiChat is trying to turn that itch into a product category with PettiLive!, a screen-based version of a pet that...

Continue Reading
Newegg’s GIGABYTE Event Is Brand Work, Not a Catalyst

Updated Category News Views 311

A 2,300-square-foot room can tell a retailer plenty about its tribe. On November 21, Newegg is turning its Diamond Bar Gamer Zone into the home base for GIGABYTE’s AORUS VS40 celebration, a free five-hour event marking the hardware maker’s 40th anniversary. There will be 1v1 VALORANT and League of Legends contests, demo stations, raffles, anniversary merchandise, food...

Continue Reading
Sitting, Lymph Flow, and a Supplement Maker's Pitch

Updated Category News Views 182

By late afternoon, a chair can feel like it has quietly won the argument against your legs. PureHealth Research is leaning into that familiar heavy, puffy-legged feeling with a reminder about lymphatic flow—and, naturally, an eight-ingredient supplement positioned alongside it. The broad message is sensible. The sales layer needs the usual healthy squint. Movement Does...

Continue Reading
ModuleMD Takes Allergy EHR AI Beyond the Usual Hype Cycle

Updated Category News Views 238

Allergy Workflows Are Where This Has to Earn Its Keep Allergy clinics do not need another shiny dashboard clogging up a workstation. They need less typing, fewer handoffs, cleaner documentation, and fewer administrative chores slipping through the cracks while a packed day keeps moving. That is the practical lens for ModuleMD's ACAAI 2026 presentation in Phoenix: not...

Continue Reading
Human Frontier Mission Puts AI Research on Display

Updated Category News Views 162

A laboratory notebook is about to become the real product in this AI experiment. Human Frontier Mission, or HFM, says it will launch globally on Nov. 24, opening a research program where domain specialists frame scientific and engineering problems while autonomous AI agents develop and test possible answers. The unusual bit is not merely handing models difficult work. It...

Continue Reading
Mission Inn’s Lights Enter a Tender New Ownership Era

Updated Category News Views 213

A holiday spectacle can outlive the hands that hung its first bulb. Riverside is about to test that truth in public, under millions of tiny lights and the very large shadow of a family departure. The Mission Inn Festival of Lights returns in 2026 without Kelly and Duane Roberts as hotel owners for the first time in more than three decades. Duane Roberts died in 2025, the...

Continue Reading
Anthropic's Leveraged ETFs Arrive After Wild Debut

Updated Category News Views 411

Nothing says a feverish new listing quite like leveraged products lining up before the opening-week confetti has settled. Anthropic priced its IPO at $83 on November 18, raised roughly $81.3 billion, then opened Nasdaq trading at $111.50 on November 19. That is an enormous gap between IPO price and first trade, and it tells investors the obvious thing: plenty of appetite...

Continue Reading
UAE Trust Model Faces Its Hardest Test During Crisis

Updated Category News Views 183

A country’s reputation is usually invisible right up until the machinery rattles. Then people, investors, trading partners and residents stop listening to polished slogans and start watching whether airports function, services hold up, information arrives, and business can keep moving. That was the useful core of Saeed Al Eter’s remarks at Ajman Media Forum 2026: soft...

Continue Reading

Top 5 Most Recently Viewed Articles

Strategic Investment by BrainsWay to Enhance Mental Health Solutions

Updated Category News Views 247

BrainsWay's Expansion Plans and Strategic Investment This investment marks BrainsWay’s entrance into the market for mental health therapies that can be administered outside of a clinic, including at home. Neurolief’s breakthrough Proliv™Rx device is pending Premarket Approval from the U.S. FDA, and if granted, it will set a precedent as the first FDA-cleared medical...

Continue Reading
Mary Street Capital: Enhancing Investment Banking Services

Updated Category News Views 300

Mary Street Capital: A New Era in Investment Banking Mary Street Capital has emerged as an innovative investment banking affiliate of Kaufman Rossin, significantly expanding its advisory capabilities. This new venture focuses on addressing the unique needs of family- and founder-owned businesses, particularly those in the middle market that have often felt overlooked by...

Continue Reading
Fluorine-18 Market Growth Driven by Cancer Diagnosis Demand

Updated Category News Views 169

Fluorine-18 Market Growth Context The global fluorine-18 market is on a notable trajectory of growth, anticipated to reach USD 2.54 billion by 2031 from USD 1.85 billion in 2024. This progression is largely influenced by the increasing incidence of cancer and the expanding utilization of nuclear imaging methodologies. The Role of Fluorine-18 in Medical Diagnostics...

Continue Reading
Masimo's smartSET™ Revolutionizes Patient Monitoring

Updated Category News Views 227

Breaking Ground in Patient Monitoring Let's dive into the gritty details behind Masimo's latest FDA-nod: the smartSET™ system. This gizmo ain't your ordinary pulse oximeter; it's a next-gen hand-holder for the medical world, poised to ride the AI wave straight into the clinic. They've cracked open a new way for clinicians to peek behind the curtain of patient vitals,...

Continue Reading
Chargeback Rates Increase Dramatically Amid Visa Changes

Updated Category News Views 320

Surge in Chargebacks Signals Major Industry Changes CLEVELAND — The payments industry is witnessing a seismic shift, with chargebacks soaring by an astonishing 222% year over year. This significant rise has impacted various sectors, including eCommerce, travel, subscription services, and healthcare. Understanding Visa's VAMP Program As Visa introduces its new Acquirer...

Continue Reading